alexa The Use Of Styrene Maleic Acid (SMA) Nanomicelles For Effective Oral Delivery Of Bioactive Therapeutics | 70080
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

13th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology
July 24-25, 2017 | Rome, Italy

Khaled Greish
Arabian Gulf University, Bahrain
ScientificTracks Abstracts: J Nanomed Nanotechnol
DOI: 10.4172/2157-7439-C1-049
Abstract
The oral route is the most preferred mode of administration among patients, due to its non-invasive nature. Oral administration of therapeutics can improve the patient`s quality of life, reduce costs associated with hospitalization and avoid complications associated with intravenous injections. The primary barrier to clinical application of an oral therapeutic, is poor oral bioavailability, a result of the combination of low water solubility, low pH stability, poor mucosal penetration, extensive first pass metabolism, and P-glycoprotein (P-gp) efflux and enzymatic degradation. Nanocarriers present a unique opportunity to overcome these barriers due to their design flexibility, surface functionality, and ability to deliver a wide range of therapeutics. Nanocarrier systems can enhance the solubility of the bioactive, protect them from enzymatic degradation and allow incorporation of the appropriate surface functionalization to favor uptake through the intestinal epithelium. Additionally, nanocarriers can prevent the direct contact of the bioactive agent with the cells of gastrointestinal (GI) tract. Nanocarriers can thus reduce the toxicity, prolong the circulatory halflife of the bioactives and accommodate targeting moieties to enhance further their prospects as site specific delivery systems. In this presentation, we will discuss our work utilizing Styrene Maleic Acid (SMA) nanomicelles for oral drug delivery through two case studies. The first example involves the use of oral paclitaxel nanomiceller formulation for treatment of colon cancer. The second case will discuss the successful use of oral nanoformulation of the selective estrogen receptor modulator (raloxifene) for treatment of Inflammatory Bowel Disease (IBD).
Biography

Khaled Greish graduated from the Faculty of Medicine, Suez Canal University, Egypt in 1992. He received his Master’s degree in Clinical Oncology in 1997. From 1999 to early 2008, he joined the lab of Professor Hiroshi Maeda, a world leader in the field of Anticancer Nanomedicine. Along with Professor Maeda, he developed an affordable platform nanotechnology micellar system for targeting anticancer drugs to solid tumors. In 2008, he moved to The University of Utah, as Research Assistant Professor. He joined Otago University in 2011, and currently Associate Professor at Arabian Gulf University, Bahrain. His areas of interest span the formulation and characterization of different advanced drug delivery systems, anticancer drug discovery/development, tumor vascular biology and animal tumor models. He was awarded the CRS Postdoctoral Achievement award in 2008 and, in 2010 he was elected as member of the CRS College of Fellows.

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version